Sanofi’s stock plunged in 2022 after a series of setbacks shook investor confidence. The French pharmaceutical giant reported weaker revenue as it stopped consolidating non-U.S. sales of its cancer drug…
Welcome to WordPress. This is your first post. Edit or delete it, then start writing!